Amarin Corp PLC (NASDAQ:AMRN) Institutional Investors Sentiment Index Up in Q2 2018

Amarin Corporation plc (NASDAQ:AMRN) Logo

Sentiment for Amarin Corp PLC (NASDAQ:AMRN)

Amarin Corp PLC (NASDAQ:AMRN) institutional sentiment increased to 1.44 in 2018 Q2. Its up 0.39, from 1.05 in 2018Q1. The ratio is better, as 49 funds increased and opened new equity positions, while 34 trimmed and sold holdings in Amarin Corp PLC. The funds in our partner’s database now own: 101.63 million shares, down from 113.30 million shares in 2018Q1. Also, the number of funds holding Amarin Corp PLC in their top 10 equity positions decreased from 3 to 2 for a decrease of 1. Sold All: 19 Reduced: 15 Increased: 34 New Position: 15.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $5.46 billion. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

The stock decreased 6.00% or $1.08 during the last trading session, reaching $16.91. About 5.76M shares traded. Amarin Corporation plc (NASDAQ:AMRN) has declined 3.76% since December 8, 2017 and is downtrending. It has underperformed by 19.38% the S&P500.

Analysts await Amarin Corporation plc (NASDAQ:AMRN) to report earnings on February, 26. They expect $-0.10 earnings per share, down 25.00 % or $0.02 from last year’s $-0.08 per share. After $-0.08 actual earnings per share reported by Amarin Corporation plc for the previous quarter, Wall Street now forecasts 25.00 % negative EPS growth.

Healthcare Value Capital Llc holds 4.38% of its portfolio in Amarin Corporation plc for 500,000 shares. Oracle Investment Management Inc owns 5.26 million shares or 3.93% of their US portfolio. Moreover, Opaleye Management Inc. has 1.4% invested in the company for 1.75 million shares. The New York-based Consonance Capital Management Lp has invested 0.99% in the stock. Baker Bros. Advisors Lp, a New York-based fund reported 22.67 million shares.

Since January 1, 0001, it had 0 buys, and 12 selling transactions for $35.91 million activity.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Ratings analysis reveals 50% of Amarin Corp’s analysts are positive. Out of 2 Wall Street analysts rating Amarin Corp, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $15 while the high is $28. The stock’s average target of $21.50 is 27.14% above today’s ($16.91) share price. AMRN was included in 4 notes of analysts from September 25, 2018. The company was maintained on Wednesday, October 17 by Citigroup. As per Friday, November 2, the company rating was downgraded by Citigroup. The company was maintained on Tuesday, September 25 by Citigroup. The firm has “Buy” rating by Jefferies given on Tuesday, September 25.

More notable recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: which released: “Signs Point to Short Squeeze for Solar Stock – Schaeffers Research” on November 27, 2018, also with their article: “Why U.S. Steel, Amarin, and Papa John’s International Slumped Today – The Motley Fool” published on November 27, 2018, published: “Amarin (AMRN) Beats Earnings & Misses Revenues in Q3 – Nasdaq” on November 01, 2018. More interesting news about Amarin Corporation plc (NASDAQ:AMRN) were released by: and their article: “Amarin Corporation plc (AMRN) CEO John Thero Presents at Evercore ISI HealthCONx Conference (Transcript) – Seeking Alpha” published on November 28, 2018 as well as‘s news article titled: “Why Amarin Corporation’s Stock Is on the Mend Today – Nasdaq” with publication date: November 15, 2018.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.